Welcome to Cohesion Biosciences
Home> Products > Primary Antibody
CPA1656
  • Western blot analysis of Cytokeratin 5 expression in HEK293T (A), Hela (B), mouse brain (C), rat brain (D) whole cell lysates. (Predicted band size: 62 kD; Observed band size: 62 kD)
  • Immunohistochemical analysis of Cytokeratin 5 staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
  • Immunofluorescent analysis of Cytokeratin 5 staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Product Name:Anti-Cytokeratin 5 Antibody
Cat No:CPA1656
Source:Rabbit
Reactivity:H, M, R, B, P
Applications:WB, IH, IF/IC, FC
*Application Key:
H - Human, M - Mouse, R - Rat, B - Bovine, C - Chicken, D - Dog, G - Goat, Mk - Monkey, P - Pig, Rb - Rabbit, S - Sheep, Z - Zebrafish
*Species Reactivity Key:
E- ELISA, WB - Western blot, IH - Immunohistochemistry, IF - Immunofluorescence, FC - Flow cytometry, IC - Immunocytochemistry, IP - Immunoprecipitation, ChIP - Chromatin Immunoprecipitation, EMSA - Electrophoretic Mobility Shift Assay, BL - Blocking, SE - Sandwich ELISA, CBE - Cell-based ELISA, RNAi - RNA interference
Size
Price(USD)
200 μl
350
100 μl
220
30 μl
110
50 μl
150
Add to cart Ship in 3 days My orders
Description:Rabbit polyclonal antibody to Cytokeratin 5
Immunogen:KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human Cytokeratin 5. The exact sequence is proprietary.
Purification:The antibody was purified by immunogen affinity chromatography.
Clonality:Polyclonal
Form:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Dilution:WB (1/500 - 1/1000), IH (1/50 - 1/100), IF/IC (1/50 - 1/200), FC (1/100 - 1/200)
Gene Symbol:KRT5
Alternative Names:Keratin, type II cytoskeletal 5; 58 kDa cytokeratin; Cytokeratin-5; CK-5; Keratin-5; K5; Type-II keratin Kb5
Entrez Gene (Human): 3852;
Entrez Gene (Mouse): 110308;
Entrez Gene (Rat): 369017;
SwissProt (Human): P13647;
SwissProt (Mouse): Q922U2;
SwissProt (Rat): Q6P6Q2;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
  • Western blot analysis of Cytokeratin 5 expression in HEK293T (A), Hela (B), mouse brain (C), rat brain (D) whole cell lysates. (Predicted band size: 62 kD; Observed band size: 62 kD)
  • Immunohistochemical analysis of Cytokeratin 5 staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
  • Immunofluorescent analysis of Cytokeratin 5 staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Stromal cell networks regulate thymocyte migration and dendritic cell behavior in the thymus
Journal J Immunol
IF 4.4
Application IHC-FoFr
Reactivity Mouse
PMID 21278345
Three differentiation states risk-stratify bladder cancer into distinct subtypes
Journal Proc Natl Acad Sci U S A
IF
Application IHC-Fr
Reactivity Human
PMID 22308455
Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
Journal Oncogene
IF 8
Application ICC/IF
Reactivity Mouse
PMID 22370636
Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma
Journal Clin Cancer Res
IF 11.5
Application IHC-P
Reactivity Mouse
PMID 22399565
Evidence for a partial epithelial-mesenchymal transition in postnatal stages of rat auditory organ morphogenesis
Journal Histochem Cell Biol
IF 2.3
Application IHC-Fr
Reactivity Rat
PMID 22610129
Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model
Journal Infect Immun
IF 3.1
Application IHC-P
Reactivity Mouse
PMID 23264047
p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model
Journal PLoS One
IF 3.7
Application
Reactivity
PMID 23658742
Cessation of epithelial Bmp signaling switches the differentiation of crown epithelia to the root lineage in a ß-catenin-dependent manner
Journal Mol Cell Biol
IF 5.3
Application
Reactivity
PMID 24081330
Epithelial basal cells are distinct from dendritic cells and macrophages in the mouse epididymis
Journal Biol Reprod
IF 3.6
Application Flow Cyt, ICC/IF
Reactivity Mouse
PMID 24648397
Loss of primary cilia occurs early in breast cancer development
Journal Cilia
IF
Application ICC/IF
Reactivity Human
PMID 24987519
PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-?B
Journal Oncogenesis
IF 6.2
Application
Reactivity
PMID 25111863
COHESION BIOSCIENCES LIMITED
Copyright © 2022 Cohesion Biosciences. All Rights Reserved